Patents by Inventor Olivier Tredan

Olivier Tredan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170342499
    Abstract: The method for predicting the anti-tumor response in a human or animal having a tumor to multiple kinase inhibitors, using any multiple kinase inhibitor, comprises selection of genes encoding for protein kinases targeted by the said tyrosine kinase inhibitor, for each one of these genes, providing at least one nucleic acid probe which hybridizes to said gene under stringent conditions, thus providing an array of nucleic acid probes, having a biological sample containing cancer cells from said human or animal, extracting DNA from the sample, fragmenting into DNA fragments, optionally labeling the DNA fragments, submitting the optionally labeled DNA fragments to hybridization with the array of nucleic acid probes, recovering and quantifying for all the genes the gains or losses in gene copy numbers, wherein gains and losses of gene copy numbers of each selected gene are used to determine whether the tumor is sensitive or not to said kinase inhibitor.
    Type: Application
    Filed: December 18, 2015
    Publication date: November 30, 2017
    Inventors: Jean-Yves BLAY, Xiaojun JIANG, Olivier TREDAN, Isabelle RAY COQUARD
  • Publication number: 20150212087
    Abstract: Detection of the ER?/Src/PI3K complex by a Proximity ligation assay as prognostic and theranostic marker in breast cancer.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 30, 2015
    Inventors: Muriel Le Romancer-Cherifi, Olivier Tredan, Isabelle Treilleux